ArticleRetina (Philadelphia, Pa.)2022

CHANGES IN SYSTEMIC LEVELS OF VASCULAR ENDOTHELIAL GROWTH FACTOR AFTER INTRAVITREAL INJECTION OF AFLIBERCEPT OR BROLUCIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.

Reinhard Angermann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.